Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-08 Purchase | 2022-08-10 8:49 pm | Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd 10% Owner | 2,150,000 | $3.5 | $7,525,000 | 11,835,673 (Direct) | View |
| 2021-12-06 Purchase | 2021-12-07 06:03 am | Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Common director with Issuer Director 10% Owner | 1,828 | $6.9 | $12,613 | 9,685,673 (Direct) | View |
| 2021-11-30 Purchase | 2021-12-02 6:33 pm | Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Common director with Issuer Director 10% Owner | 51,253 | $6.8522 | $351,194 | 9,683,845 (Direct) | View |
| 2021-11-24 Purchase | 2021-11-29 7:55 pm | Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Common director with Issuer Director 10% Owner | 39,362 | $6.833 | $268,962 | 9,632,592 (Direct) | View |
| 2021-11-19 Purchase | 2021-11-23 6:41 pm | Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Common director with Issuer Director 10% Owner | 25,729 | $7.0597 | $181,640 | 9,593,230 (Direct) | View |
| 2021-11-16 Purchase | 2021-11-18 8:24 pm | Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Common director with Issuer Director 10% Owner | 379,376 | $7.201 | $2,731,889 | 9,567,501 (Direct) | View |
| 2019-06-28 Sale | 2019-07-02 9:45 pm | Novan Inc. | NOVN | Malin Life Sciences Holdings Ltd Malin Corp plc 10% Owner | 25,000 | $2.7069 | $67,673 | 2,598,485 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-07-14 Conversion | 2020-07-15 5:00 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Malin Corp plc 10% Owner | 20,645,718 | $0 | 9,188,125 (Direct) | View |
Ownership | 2020-07-09 6:20 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Malin Corp plc 10% Owner | 0 | $0 | 9,188,125 (Direct) | View |